Inhibition of E protein and differentiation blockade were, however, insufficient for leukemogenesis since most SCL transgenic lines did not develop T-ALL [40], [51], [52], with the exception of one transgenic model [53], [54]. Here, TAL1 is linked to acute lymphoblastic leukemia.